SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-006937
Filing Date
2023-03-07
Accepted
2023-03-07 17:25:18
Documents
13
Period of Report
2023-03-06
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41460
2 ex16-1.htm EX-16.1 5861
  Complete submission text file 0001493152-23-006937.txt   223720

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bixt-20230306_lab.xml EX-101.LAB 34240
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bixt-20230306_pre.xml EX-101.PRE 22367
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bixt-20230306.xsd EX-101.SCH 3297
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3592
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35027 | Film No.: 23713894
SIC: 2834 Pharmaceutical Preparations